BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 10586249)

  • 1. Transgenic mouse models of CMT1A and HNPP.
    Suter U; Nave KA
    Ann N Y Acad Sci; 1999 Sep; 883():247-53. PubMed ID: 10586249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic Mouse Models of CMT1A and HNPP.
    Suter U; Nave KA
    Ann N Y Acad Sci; 1999 Oct; 883(1):247-253. PubMed ID: 29086924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypermyelination and demyelinating peripheral neuropathy in Pmp22-deficient mice.
    Adlkofer K; Martini R; Aguzzi A; Zielasek J; Toyka KV; Suter U
    Nat Genet; 1995 Nov; 11(3):274-80. PubMed ID: 7581450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic basis of inherited peripheral neuropathies.
    Suter U; Patel PI
    Hum Mutat; 1994; 3(2):95-102. PubMed ID: 7515304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Many facets of the peripheral myelin protein PMP22 in myelination and disease.
    Naef R; Suter U
    Microsc Res Tech; 1998 Jun; 41(5):359-71. PubMed ID: 9672419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct disease mechanisms in peripheral neuropathies due to altered peripheral myelin protein 22 gene dosage or a Pmp22 point mutation.
    Giambonini-Brugnoli G; Buchstaller J; Sommer L; Suter U; Mantei N
    Neurobiol Dis; 2005 Apr; 18(3):656-68. PubMed ID: 15755691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation analysis of PMP22 in Slovak patients with Charcot-Marie-Tooth disease and hereditary neuropathy with liability to pressure palsies.
    Resko P; Radvansky J; Odnogova Z; Baldovic M; Minarik G; Polakova H; Palffy R; Kadasi L
    Gen Physiol Biophys; 2011 Dec; 30(4):379-88. PubMed ID: 22131320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human nerve pathology caused by different mutational mechanisms of the PMP22 gene.
    Gabreëls-Festen A; Wetering RV
    Ann N Y Acad Sci; 1999 Sep; 883():336-43. PubMed ID: 10586258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hereditary neuropathy with liability to pressure palsies: study of six Spanish families].
    Pou Serradell A; Monells J; Téllez MJ; Fossas P; Löfgren A; Meuleman J; Timmerman V; De Jonghe P; Ceuterick C; Martin JJ
    Rev Neurol (Paris); 2002 May; 158(5 Pt 1):579-88. PubMed ID: 12072826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Charcot-Marie-Tooth disease and related peripheral neuropathies.
    De Jonghe P; Timmerman V; Nelis E; Martin JJ; Van Broeckhoven C
    J Peripher Nerv Syst; 1997; 2(4):370-87. PubMed ID: 10975746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the regulatory region of the peripheral myelin protein 22 (PMP22) gene that directs temporal and spatial expression in development and regeneration of peripheral nerves.
    Maier M; Berger P; Nave KA; Suter U
    Mol Cell Neurosci; 2002 May; 20(1):93-109. PubMed ID: 12056842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of hereditary neuropathies.
    Chance PF
    Phys Med Rehabil Clin N Am; 2001 May; 12(2):277-91. PubMed ID: 11345007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The alpha-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultured Schwann cells.
    Barbaria EM; Kohl B; Buhren BA; Hasenpusch-Theil K; Kruse F; Küry P; Martini R; Müller HW
    Neurobiol Dis; 2009 Mar; 33(3):448-58. PubMed ID: 19111616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four novel point mutations in the PMP22 gene with phenotypes of HNPP and Dejerine-Sottas neuropathy.
    Brožková D; Mazanec R; Rychlý Z; Haberlová J; Böhm J; Staněk J; Plevová P; Lisoňová J; Sabová J; Sakmaryová I; Seeman P
    Muscle Nerve; 2011 Nov; 44(5):819-22. PubMed ID: 22006697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trembler as a mouse model of CMT1A?
    Garbay B; Salles J; Knoll A; Boiron-Sargueil F; Heape AM; Bonnet J; Cassagne C
    Ann N Y Acad Sci; 1999 Sep; 883():262-72. PubMed ID: 10586251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies.
    Hanemann CO; Stoll G; D'Urso D; Fricke W; Martin JJ; Van Broeckhoven C; Mancardi GL; Bartke I; Müller HW
    J Neurosci Res; 1994 Apr; 37(5):654-9. PubMed ID: 8028042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New vistas on the pathomechanism of Charcot-Marie-Tooth and related peripheral neuropathies.
    Müller HW
    Ann N Y Acad Sci; 1999 Sep; 883():152-9. PubMed ID: 10586241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of compound heterozygous mice reveals that the Trembler mutation can behave as a gain-of-function allele.
    Adlkofer K; Naef R; Suter U
    J Neurosci Res; 1997 Sep; 49(6):671-80. PubMed ID: 9335255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the peripheral myelin genes and associated genes in inherited peripheral neuropathies.
    Nelis E; Haites N; Van Broeckhoven C
    Hum Mutat; 1999; 13(1):11-28. PubMed ID: 9888385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease.
    Nobbio L; Vigo T; Abbruzzese M; Levi G; Brancolini C; Mantero S; Grandis M; Benedetti L; Mancardi G; Schenone A
    Neurobiol Dis; 2004 Jun; 16(1):263-73. PubMed ID: 15207283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.